High-level penicillin G-resistant as well as multidrug-resistant
Streptococcus pneumoniae continues to be a significant cause of morbidity and mortality in humans, causing pneumonia, acute exacerbations of chronic bronchitis, sinusitis, otitis media, bacteremia, meningitis, and other diseases (17) . While pneumococci were exquisitely susceptible to penicillin G when this agent was first introduced in the 1940s, with MICs of 0.008 to 0.015 g/ml, laboratory mutants with higher MICs were selected soon after the drug was introduced (6) . Clinical isolates with higher penicillin G MICs were first described 20 years later, when investigators in Boston, Mass., noted penicillin G MICs of 0.1 to 0.2 g/ml for 2 of 200 isolates (13) . Hansman and Bullen were the first researchers to realize the significance of higher penicillin G MICs in S. pneumoniae when they isolated a strain exhibiting a penicillin G MIC of 0.6 g/ml in Australia from the sputum of a patient with hypogammaglobulinemia (11) .
Little attention was paid to antimicrobial resistance in pneumococci until 1977, when pneumococci with considerably higher levels of penicillin G resistance (2 to 8 g/ml) were described for patients in Durban, South Africa, with meningitis, bacteremia, pneumonia, and empyema (1) . In the same year, Jacobs and coworkers isolated isolates with similar penicillin G and chloramphenicol resistance levels in Johannesburg, South Africa; these isolates were also highly resistant to macrolides, lincosamides, tetracycline, and trimethoprim-sulfamethoxazole (12) .
Since then, resistant pneumococci have been identified globally in steadily increasing numbers, especially since the late 1980s. Rates of penicillin G resistance among pneumococci are as high as 60% in some parts of Latin America and as high as 80% in some countries in Asia (2), and multiply resistant pneumococcal isolates are now seen worldwide (20) .
In addition, resistance to macrolides is increasing worldwide (20) . The most prevalent mechanisms of macrolide resistance in S. pneumoniae are mediated by mef(A), a gene encoding an efflux pump, and erm(B), a 23S rRNA methylase that methylates adenine in position 2058, resulting in constitutive macrolide-lincosamide-streptogramin B (cMLS B ) resistance. In addition, mutations in the 23S rRNA gene and ribosomal proteins L4 and L22 have recently been shown to cause resistance in pneumococci (19) . The main epidemiological marker used to distinguish between pneumococcal isolates is the capsular serotype, with 90 serotypes currently being recognized. More sophisticated epidemiologic markers have subsequently become available, and multilocus sequence typing (MLST) is a recently developed technique that produces unambiguous molecular typing data that can be transmitted electronically via the Internet (http://www. mlst.net) (5, 15) .
The present study uses modern molecular methods, including this technique, to analyze resistant S. pneumoniae isolates from South Africa (1977 to 1978), which were available in the isolate collections of authors who originally described these isolates, and to compare results from these isolates with those of other isolates of S. pneumoniae encountered worldwide.
MATERIALS AND METHODS
Bacterial isolates. Twenty-six pneumococcal isolates, representative of the serotypes and resistance patterns of the original South African isolates and which had been isolated from patients or carriers in Johannesburg and Durban from 1977 to 1978, had been stored at Ϫ70°C since their initial isolation and were available for the current study. The identity of isolates as S. pneumoniae isolates was confirmed by optochin sensitivity and bile solubility testing, and the capsular type was also verified (3, 9) . Susceptibility testing. MIC testing was performed using the broth microdilution method recommended by the Clinical Laboratory Standards Institute (CLSI) (4) . Dried microtiter plates (Sensititre Susceptibility Plates; TREK Diagnostic Systems Ltd., East Grinstead, West Sussex, England) containing penicillin G, cefotaxime, amoxicillin, clarithromycin, clindamycin, tetracycline, telithromycin, levofloxacin, trimethoprim-sulfamethoxazole, and chloramphenicol were reconstituted with cation-adjusted Mueller-Hinton broth (Oxoid, Wesel, Germany) plus 5% lysed horse blood (Oxoid) with inocula of 5 ϫ 10 5 CFU/ml. MICs were determined following incubation at 35°C for 20 to 24 h in ambient air and interpreted according to current CLSI (formerly NCCLS) interpretive criteria. For penicillin G, breakpoints of 0.1 to 1 g/ml (intermediate) and Ն2 g/ml (resistant) were used (4). S. pneumoniae ATCC 49619 was included as a control strain.
Determination of resistance genotypes and phenotypes. Primers described previously by Tait-Kamradt et al. and Trieu-Cuot et al. were chosen for detection of erm(B) and mef genes in macrolide-resistant isolates (24, 26) . Preparation of DNA and real-time PCR were performed as described previously (21) . Macrolide resistance phenotypes were determined as described previously (16) .
Serotyping. Isolates were serotyped by Neufeld's capsular swelling reaction using type and factor sera obtained from the Statens Serum Institut, Copenhagen, Denmark (18) .
PFGE. Genetic relatedness of the isolates was investigated by pulsed-field gel electrophoresis (PFGE) using SmaI digests of chromosomal DNA. Restriction fragments were separated in 1% agarose gels and electrophoresed for 20 h according to the instructions of the manufacturer (GenePath strain typing system; Bio-Rad, Hercules, CA). PFGE patterns were analyzed visually and compared according to standard criteria (25) .
MLST. MLST was carried out as described previously (5) . Briefly, internal fragments of the aroE, gdh, gki, recP, spi, xpt, and ddl genes were amplified by PCR from chromosomal DNA with the primer pairs described previously by Enright and Spratt (5) . The alleles at each of the seven loci provided the allelic profile of each isolate and also defined their sequence types (STs). The allelic profiles of the South African isolates were compared with each other as well as with other isolates in the pneumococcal MLST database using software available at the MLST website (http://www.mlst.net).
Phylogenetic analysis. MLSTs were analyzed using the program eBURST. This program is able to display the relationships between closely related isolates of a bacterial species or population. eBURST, unlike cluster diagrams, trees, or dendrograms, uses a simple but appropriate model of bacterial evolution in which an ancestral (or founding) genotype increases in frequency in the population and while doing so begins to diversify to produce a cluster of closely related genotypes that are all descended from the founding genotype. This cluster of related genotypes is referred to as a "clonal complex" (http://eburst .mlst.net) (8 
RESULTS
Twenty-six antibiotic-resistant S. pneumoniae strains isolated in South Africa from 1977 to 1978 were available for the present investigation, with 25 isolates originating from Johannesburg and 1 isolate (isolate 638) originating from Durban. The antimicrobial susceptibility pattern of isolate 638 was identical to that of the five original penicillin G-and chloramphen- MLST 172 is part of a group composed of 89 sequence types, all connected by SLVs. The predicted founder of this group is MLST 176, represented by serotype 6B/serotype 6A isolates from the United Kingdom, Canada, Italy, Kuwait, and Poland (Fig. 1A) . In this analysis, ST 172 is the founder of a subgroup with six SLVs (ST 361, ST 1131, ST 1150, ST 1373, ST 1447, and ST 1526). These strains were isolated in the Philippines, a Abbreviations: p, penicillin G intermediate; P, penicillin G resistant; M, macrolide resistant; L, lincosamide resistant; C, chloramphenicol resistant; T, tetracycline resistant; S, trimethoprim-sulfamethoxazole resistant. Breakpoints (intermediate and resistant, respectively) according to CLSI are as follows: penicillin G, 0.12 to 1 g/ml and Ն2 g/ml; erythromycin A (macrolide), 0.5 g/ml and Ն 1 g/ml; clindamycin (lincosamide), 0.5 g/ml and Ն 1 g/ml; chloramphenicol, not determined and Ն8 g/ml; tetracycline, 4 g/ml and Ն8 g/ml; trimethoprim-sulfamethoxazole, 1/19 g/ml 2/38 g/ml, and Ն4/76 g/ml. (Fig. 1B) . ST 124 isolates were reported from Germany, The Netherlands, Scandinavia, the United Kingdom, Australia, and Canada. All isolates in the database were reported to be penicillin G and macrolide susceptible, with the exception of one macrolide-resistant penicillin G-intermediate isolate from Germany. Other members of this group are mostly penicillin and erythromycin susceptible (1 out of 41 was penicillin intermediate, and 6 out of 41 were macrolide resistant).
PFGE patterns generally correlated with ST results. The six isolates of ST 41 (serotype 19A) showed five PFGE profiles (B, C, C2, C3, and D). The isolates of ST 1094 (serotype 19A) were more closely related by PFGE and showed only four profiles (A1, E, F, and F1) (Fig. 2) .
DISCUSSION
The first description of pneumococci that were highly resistant to penicillin G was reported previously by Appelbaum et al. in Durban, South Africa, in 1977 (1). The patients described were five children aged between 3 and 24 months, presenting between March and May 1977, and all had received penicillin G or chloramphenicol for relatively long periods prior to the development of these infections, with three of the cases being nosocomial. The pneumococci isolated from these five patients were all serotype 19A and were resistant to penicillin G (MICs, 4 g/ml), ampicillin (MICs, 2 g/ml), chloramphenicol (MICs, 16 g/ml), and trimethoprim-sulfamethoxazole (MICs, 2/38 g/ml) (1, 27) . Initial surveillance studies of nasopharyngeal carriage of resistant pneumococci among hospital contacts and outpatients in Durban did not yield any such isolates. These findings in Durban were followed by the isolation of multidrugresistant serotype 19A pneumococci in Johannesburg in July For many years, epidemiologic discrimination of pneumococcal clones has been based on capsular serotyping. PFGE and MLST were then introduced and were highly discriminative for pneumococcal isolates, and the results of the two methods were generally in agreement (22) . In addition, DNA fingerprinting of penicillin-binding protein genes and arbitrarily primed PCR were used to identify predominant penicillinresistant South African clones isolated from 1987 to 1989 (23) .
Most of the clones found in South Africa in the 1970s do not appear to have spread to other countries, with the exception of ST 124 and ST 172. In a study of the clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States, Gertz et al. reported that ST 124, which was demonstrated to be a founder of a clonal complex by the present study, accounted for a large percentage of penicillin-sensitive type 14 isolates (10). ST 172 was also described as a serotype 19A strain isolated in the United Kingdom in 1996 from a patient with meningitis. Interestingly, this related isolate was found in a country with strong historic relationships to South Africa, suggesting that the spread of pneumococcal clones may in part parallel human migration to and from these countries. The latter finding has also been observed in other genetically more conserved species, such as Helicobacter pylori (7) .
In summary, modern molecular methods have allowed us to characterize the first highly penicillin G-resistant isolate and many multidrug-resistant isolates of S. pneumoniae that had been isolated from 1977 to 1978 in South Africa and to show the relationship of these isolates to other international pneumococcal clones. The serotype 14 South African isolate from 1977 appears to be more widespread and more related to other pneumococcal clones in several countries than the serotype 6A and 19A isolates from this time period.
